HAVCR2 and hepatocellular carcinoma: TIM3 is expressed on tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) of human HCC and negatively regulates the effector function of T cells, whereas its expression on Treg cells results in enhanced suppressor activity (27, 30, 31).